Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
This is a summary. Read the complete story at the original publisher:
Read the full article on Al Jazeera →